From the ∗Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL
†Department of Medicine, Emory University, Atlanta, GA
‡FHI 360, Durham, NC
§Department of Medicine, Section of Infectious Diseases, Louisiana State University Health Sciences Center, New Orleans, LA
¶The Fenway Institute, Fenway Health, and Department of Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA
∥Department of Medicine, Section on Infectious Diseases, Wake Forest School of Medicine, Winston-Salem, NC
∗∗Department of Medicine, Johns Hopkins University, Baltimore, MD
††Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA
‡‡Department of Medicine, Indiana University School of Medicine, Indianapolis, IN
§§Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
¶¶Department of Obstetrics, Gynecology and Reproductive Sciences, and Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, PA
∥∥Enteric and Sexually Transmitted Infections Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
Conflict of Interest and Sources of Funding: The authors declare no conflict of interest.
This work was funded by the National Institute of Allergy and Infectious Diseases (Sexually Transmitted Infections Clinical Trials Group) Contract HHSN272201300012I. The views and opinions presented do not reflect those of the funding agency. J.D.-O. reports research funding from National Institutes of Health/National Institute of Child Health and Human Development 1R01HD101545.
Correspondence: Jodie Dionne-Odom, MD, MSPH, University of Alabama at Birmingham, Birmingham, AL. E-mail: [email protected].
Received for publication November 17, 2021, and accepted January 10, 2022.
